Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1136/pgmj.68.798.289 http://scihub22266oqcxt.onion/10.1136/pgmj.68.798.289 1409197!2399266!1409197     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Postgrad+Med+J 1992 ; 68 (798): 289-90 Nephropedia Template TP {{tp|p=1409197|t=1992. Sotalol-induced torsade de pointes: management with magnesium infusion |pdf=|usr=}}{{1409197}} gab.com Text Sotalol-induced torsade de pointes: management with magnesium infusion JO: Postgrad Med J http://www.kidney.de/pget.php?&tw=1&pmid=1409197 #FOAvip A 69 year old woman was treated with sotalol (320 mg daily) for intermittent atrial fibrillation. Sotalol was initially well tolerated and reversion to sinus rhythm with sinus bradycardia occurred 4 weeks after initiation of therapy. Shortly thereafter, the patient developed recurrent syncope due to torsade de pointes. This was treated successfully with intravenous magnesium infusion and withdrawal of sotalol. Subsequently, the atrial fibrillation was adequately managed using amiodarone, with no recurrence of torsade de pointes. Development of bradycardia associated with reversion to sinus rhythm represents a potential cause of 'late' pro-arrhythmic effects of sotalol. Twit Text FOAVip Sotalol-induced torsade de pointes: management with magnesium infusion ????Postgrad Med J http://www.kidney.de/pget.php?&tw=1&pmid=1409197 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=1409197 #FOAvip English Wikipedia <ref>{{Cite pmid|1409197}}</ref> Sotalol-induced torsade de pointes: management with magnesium infusion #MMPMID1409197 Arstall MA; Hii JT; Lehman RG; Horowitz JD Postgrad Med J 1992[Apr]; 68 (798): 289-90 PMID1409197show ga A 69 year old woman was treated with sotalol (320 mg daily) for intermittent atrial fibrillation. Sotalol was initially well tolerated and reversion to sinus rhythm with sinus bradycardia occurred 4 weeks after initiation of therapy. Shortly thereafter, the patient developed recurrent syncope due to torsade de pointes. This was treated successfully with intravenous magnesium infusion and withdrawal of sotalol. Subsequently, the atrial fibrillation was adequately managed using amiodarone, with no recurrence of torsade de pointes. Development of bradycardia associated with reversion to sinus rhythm represents a potential cause of 'late' pro-arrhythmic effects of sotalol. |Aged[MESH] |Amiodarone/therapeutic use[MESH] |Atrial Fibrillation/*drug therapy[MESH] |Dose-Response Relationship, Drug[MESH] |Electrocardiography, Ambulatory/drug effects[MESH] |Female[MESH] |Humans[MESH] |Magnesium Sulfate/therapeutic use[MESH] |Recurrence[MESH] |Sotalol/*adverse effects/therapeutic use[MESH]Sotalol-induced torsade de pointes: management with magnesium infusion(epmc).pdf DeepDyve Pubget Overpricing